PneumaCare
Cambridge, GB · 1 known investors
PneumaCare develops Structured Light Plethysmography (SLP) technology and markets Thora-3Di, a non-contact, non-invasive 3D-imaging device for lung function assessment used in paediatric, ICU, and thoracic surgery hospital settings. The company serves clinicians assessing respiratory conditions such as COPD, with a UK/Cambridge base.
Founders & leadership
BA
Bart A. LewinChief Executive Officer
Investors · 1
Frequently asked questions
- What does PneumaCare do?
- PneumaCare develops Structured Light Plethysmography (SLP) technology and markets Thora-3Di, a non-contact, non-invasive 3D-imaging device for lung function assessment used in paediatric, ICU, and thoracic surgery hospital settings. The company serves clinicians assessing respiratory conditions such as COPD, with a UK/Cambridge base.
- Who are PneumaCare's investors?
- PneumaCare's investors include Cambridge Angels group.
- Where is PneumaCare headquartered?
- PneumaCare is headquartered in Cambridge, GB.